Telegraph Hill Partners

Telegraph Hill Partners investment thesis

Meet the Team View All J. Matthew Mackowski Chairman, Managing Director jmm@thpartners.net Matt has been a healthcare-focused venture capital investor since 1980 and began his career as an investment professional with Citicorp Venture Capital.  In 1991 he formed Mackowski & Shepler, the predecessor to Telegraph Hill Partners, and over nine years took an active or founding role with eight companies, primarily in medical and life science technologies.  Matt has represented THP on the boards of Althea Technologies (acquired by Ajinomoto), Ambion (acquired by Applied Biosystems), Asuragen (acquired by Bio-Techne), Emerging Therapy Solutions, Interface Associates (acquired by NDC), Kinetikos Medical (acquired by Integra), Magstim, MedPricer (acquired by Premier), Teknova (NASDAQ:TKNO), and Trak

Telegraph Hill Partners team (11)

Partners and principals at Telegraph Hill Partners:

• Rob Capone — sweet spot $1.5M
• Gary Curtis — sweet spot $1.5M
• Alex Efron — sweet spot $1.5M
• Paul Grossman — sweet spot $1.5M
• F. Joseph Halcomb III — sweet spot $1.5M
• Rob Hart — sweet spot $1.5M
• Alex Herzick — sweet spot $1.5M
• Deval Lashkari — sweet spot $1.5M
• Tom Raffin — sweet spot $1.5M
• Robert Shepler — sweet spot $1.5M
• Jeanette Welsh — sweet spot $1.5M

Telegraph Hill Partners portfolio companies

Companies listed on Telegraph Hill Partners's public materials include: Skip to content, Strategy, Portfolio, Team, News, All Companies Active Realized, All Companies, Active, Realized, Email, info@thpartners.net, Client Login, FIS Login, Address, Powered by MITO.

Is Telegraph Hill Partners a fit for your round?

Upload your pitch deck and see whether anyone at Telegraph Hill Partners appears in your top matches.